Hennion & Walsh Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Hennion & Walsh Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$687K	Buy	3,610 +100	+3%	+$17.2K	0.02%	666
2026 Q1	$593K	Hold	3,510	–	–	0.02%	668
2025 Q4	$592K	Hold	3,510	–	–	0.02%	662
2025 Q3	$507K	Hold	3,510	–	–	0.02%	701
2025 Q2	$444K	Hold	3,510	–	–	0.02%	709
2025 Q1	$449K	Hold	3,510	–	–	0.02%	666
2024 Q4	$464K	Hold	3,510	–	–	0.02%	640
2024 Q3	$509K	Hold	3,510	–	–	0.02%	611
2024 Q2	$482K	Hold	3,510	–	–	0.02%	603
2024 Q1	$482K	Hold	3,510	–	–	0.03%	576
2023 Q4	$477K	Hold	3,510	–	–	0.03%	561
2023 Q3	$429K	Hold	3,510	–	–	0.03%	560
2023 Q2	$446K	Hold	3,510	–	–	0.03%	540
2023 Q1	$453K	Hold	3,510	–	–	0.03%	525
2022 Q4	$461K	Hold	3,510	–	–	0.03%	516
2022 Q3	$411K	Hold	3,510	–	–	0.03%	527
2022 Q2	$412K	Hold	3,510	–	–	0.03%	532
2022 Q1	$457K	Hold	3,510	–	–	0.02%	532
2021 Q4	$535K	Hold	3,510	–	–	0.03%	525
2021 Q3	$567K	Hold	3,510	–	–	0.03%	482
2021 Q2	$574K	Hold	3,510	–	–	0.03%	489
2021 Q1	$528K	Buy	+3,510	New	+$558K	0.03%	490

Other funds holding IBB

GIC

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

FNFDCM

Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

RFA

Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

MCG

McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

Hennion & Walsh Asset Management's IBB Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its iShares Biotechnology ETF (IBB) stake by 2.8% in Q2 2026, buying an estimated $17.2K and bringing the position to 3,610 shares worth $687K. The position accounts for 0.02% of the portfolio, ranked #666.

Hennion & Walsh Asset Management first reported a position in IBB in Q1 2021 and has held it in 22 quarters since. 178 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Hennion & Walsh Asset Management held 3,610 shares of iShares Biotechnology ETF worth $687K as of Q2 2026.
Hennion & Walsh Asset Management bought 100 iShares Biotechnology ETF shares in Q2 2026, an estimated $17.2K.
iShares Biotechnology ETF made up 0.02% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #666 holding.
Hennion & Walsh Asset Management first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 22 quarters since.
178 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.